Skip to Main Content
Our Commitment to Diversity

COVID-19: K&L Gates Triage: CMS Cease and Desist Letters to COVID Labs and Reimbursement Dispute

Share via LinkedIn
Share via Twitter
Share via Facebook
Date: 23 October 2020
Triage
By: Stephen D. Bittinger

In this episode, Stephen Bittinger discusses the recent announcement that cease and desist letters from the Centers for Medicare & Medicaid Services (CMS) have been sent to 171 facilities testing for COVID-19 without proper CLIA certifications. Stephen outlines the impact of these cease and desist letters to the facilities, including potential implications for reimbursement of COVID-19 testing.

Stephen D. Bittinger
Stephen D. Bittinger
Charleston
Washington DC
Find more items tagged as: Health Care and FDA, Health Care Sector, Policy and Regulatory, Responding to COVID-19
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel